CDC study finds Moderna vaccine is best at preventing Covid-19 hospitalization

The Moderna vaccine additionally produced increased post-vaccination antibody ranges than the Pfizer-BioNTech vaccine, the study discovered.

The study excluded immunocompromised individuals.

The CDC has launched a number of research trying at vaccine efficacy specifically teams, equivalent to frontline well being care staff, because the administration prepares to roll out boosters to at least some adults within the coming weeks. While a few of these research have included information on efficacy of the assorted vaccines, the study revealed Friday gives higher perception into the extent to which Moderna, Pfizer-BioNTech and Johnson & Johnson shield towards extreme illness and Covid-19 hospitalization.

The information from the current CDC cohort study means that the two-dose Moderna and Pfizer-BioNTech vaccine regimens shield higher towards hospitalization than the single-dose Johnson & Johnson shot. However, the Johnson & Johnson vaccine nonetheless diminished threat of Covid-19-related hospitalization by 71 p.c.

Although the efficacy of the vaccines different, the CDC study confirmed that all the FDA-approved Covid-19 vaccines nonetheless work nicely at defending towards Covid-19 hospitalization.

Source link